Stay updated on AK104 Adjuvant Therapy in HCC Clinical Trial
Sign up to get notified when there's something new on the AK104 Adjuvant Therapy in HCC Clinical Trial page.

Latest updates to the AK104 Adjuvant Therapy in HCC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2 and removed a funding/operating-status notice; these are administrative updates and do not alter the trial details or data.SummaryDifference0.9%

- Check21 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and NIH Clinical Center operating status, with guidance to cc.nih.gov and opm.gov. Updated the record history revision from v3.4.0 to v3.4.1.SummaryDifference0.9%

- Check28 days agoChange DetectedUI changes to the study record history page introduce a 'Show glossary' option and color-coded highlights for additions and deletions, and update the revision label to 'Revision: v3.4.0' while removing the older 'Revision: v3.3.4' and 'No FEAR Act data'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check42 days agoChange DetectedA new revision v3.3.4 has been added to the record history and v3.3.3 removed. No changes to study data, status, or page content were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded Revision: v3.3.3 to the Record History. Removed HHS Vulnerability Disclosure and Revision: v3.3.2 from the footer.SummaryDifference0.2%

- Check91 days agoChange DetectedThe page history shows a new revision, v3.3.2, replacing v3.2.0, with no substantive changes to the study record. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to AK104 Adjuvant Therapy in HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK104 Adjuvant Therapy in HCC Clinical Trial page.